⏳ Fetching live dividend data...
Home › Calculator › HDII Dividend Calculator 2026
Hypertension Diagnostics, Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in HDII → $3.603059672953261e+54M in 10 years · $300,254,958,085,218,450,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
Hypertension Diagnostics, Inc. (HDII) is a company that designs, develops, manufactures, and commercializes its own innovative, non-invasive medical technologies. These devices are engineered to identify minute changes in the flexibility of arteries, serving both domestic and international markets. Central to their offerings is the CVProfilor, a system designed for non-invasive assessment of both large and small artery elasticity. The elasticity of small arteries is especially critical, serving as the earliest and most sensitive indicator of cardiovascular disease. The product suite includes the CVProfilor DO-2020, which delivers essential arterial elasticity indices, aiding in the diagnosis of underlying vascular conditions. Its counterpart, the CVProfilor MD-3000, offers precise and specific insights into the presence of blood vessel disease. For scientific study, the HD/PulseWave CR-2000 is a specialized cardiovascular profiling system, equipping scientists and investigators with a non-intrusive method to evaluate arterial elasticity across diverse human research domains. These devices operate by capturing 30 seconds of blood pressure waveform data, subsequently analyzing the digitized patterns to generate a comprehensive CVProfile report. This report details crucial metrics including blood pressure, heart rate, pulse pressure, body surface area, body mass index, and indices for both C1 (large) and C2 (small) artery elasticity. HDII caters to a broad spectrum of clients, including general practitioners, cardiologists, various healthcare practitioners, skilled medical staff, academic and government research scientists, cardiovascular specialists, and pharmaceutical companies. In the U.S., sales are facilitated by a dedicated network of representatives. Established in 1988, Hypertension Diagnostics, Inc. maintains its headquarters in Richmond Hill, Canada.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open HDII position with:
Real after-tax yield depends on where you live and how you hold HDII.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1600000.00% | 1599997.20% | $160,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1825000.00% | 1824997.20% | $182,500,000 / yr |
| 🇨🇦 TFSA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 1500000.00% | 1499997.20% | $150,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1472500.00% | 1472497.20% | $147,250,000 / yr |
| 🇫🇷 FR Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
HDII pays quarterly — 4 times per year. Next ex-div: TBD.
How HDII compares to typical Financial Services averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HDII sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2012-02-10 | 9,062,907 | — | — | ||
| G-Gift | 2012-02-10 | 500,000 | — | — | ||
| A-Award | 2010-12-16 | 400,000 | $0.10 | $40.0K | ||
| A-Award | 2010-12-16 | 225,000 | $0.10 | $22.5K | ||
| A-Award | 2010-12-16 | 225,000 | $0.10 | $22.5K | ||
| A-Award | 2010-12-16 | 225,000 | $0.10 | $22.5K | ||
| A-Award | 2010-12-16 | 225,000 | $0.10 | $22.5K | ||
| A-Award | 2010-10-01 | 712,433 | $0.30 | $213.7K | ||
| D-Return | 2010-10-05 | 151,708 | $0.30 | $45.5K | ||
| A-Award | 2010-10-01 | 407,105 | $0.22 | $89.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HDII dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Hypertension Diagnostics, Inc. (HDII) is currently trading at $0.00, 100% below its 52-week high. The current dividend yield is 2000000.00% based on an annual payout of $2.00 per share.
Hypertension Diagnostics, Inc. (HDII) is a financial services stock currently trading at $0.00 with a dividend yield of 2000000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever